Recombinant TNFSF4 (Oxelumab Biosimilar) anticorps

N° du produit ABIN5564244

L’anticorps anti-TNFSF4 (Oxelumab Biosimilar) Monoclonal Human est utilisé pour la détection de TNFSF4 (Oxelumab Biosimilar) dans des échantillons de Humain. Il a été validé pour FACS et Func.

Aperçu rapide pour Recombinant TNFSF4 (Oxelumab Biosimilar) anticorps (ABIN5564244)

Antigène: TNFSF4 (Oxelumab Biosimilar)

Type d'anticorp: Recombinant Antibody

Reactivité: Humain

Hôte: Human

Clonalité: Monoclonal

Conjugué: Cet anticorp TNFSF4 (Oxelumab Biosimilar) est non-conjugé

Application: Flow Cytometry (FACS), Functional Studies (Func)

Clone: R4930

Détail du produit anti-TNFSF4 (Oxelumab Biosimilar) anticorps

Fonction: anti-OX40L (human), mAb (rec.) (blocking) (R4930) (preservative free)

Specificité: Recognizes human OX40L.

Attributs du produit: Recombinant Antibody. Recognizes human OX40L. Species cross-reactivity: Human. Clone: R4930. Isotype: Human IgG1kappa. Applications: FACS, FUNC, FUNC (Blocking). Host: CHO cells. Liquid. In PBS. OX40L is a membrane-expressed cytokine that belongs to the TNF ligand family. It acts as costimulator through interaction with its ligand OX40 on T cells, stimulating T cell activation, proliferation and cytokine production. OX40L is expressed on antigen presenting cells including B cells, dendritic cells, mast cells and endothelium.

Pureté: >95 % (SDS-PAGE)

niveau d'endotoxine: <0.001EU/μg

Immunogène: Recombinant human OX40L.

Isotype: IgG1 kappa

Information d'application

Commentaires:

This antibody is a biosimilar generically called Oxelumab (CAS 1186098-83-8) and originally developed by Genentech. Oxelumab is a OX40 ligand blocker designed for the prevention of allergen-induced airway inflammation in adults with mild asthma. Potentially other application areas are transplantation and autoimmunity research or protection against inflammation-driven fibrosis.

Restrictions: For Research Use only

Stockage

Format: Liquid

Concentration: 1 mg/mL

Buffer: In PBS.

Agent conservateur: Without preservative

Conseil sur la manipulation: Avoid freeze/thaw cycles.

Stock: 4 °C,-20 °C

Stockage commentaire:

+4°C

-20°C

Stable for at least 1 year after receipt when stored at -20°C. Stable for at least 3 months after receipt when stored at +4°C.

Date de péremption: 12 months

Détails sur TNFSF4 (Oxelumab Biosimilar)

Antigène: TNFSF4 (Oxelumab Biosimilar)

Classe de substances: Biosimilar

Sujet:

Alternate Names/Synonyms: CD252, CD134L, OX40 Ligand, TNFSF4, Tumor Necrosis Factor Superfamily Member 4, TAX Transcriptionally-activated Glycoprotein 1, TXGP1, gp34

Product Description: OX40L [CD252, CD134L] is a membrane-expressed cytokine that belongs to the TNF ligand family. It acts as costimulator through interaction with its ligand OX40 on T cells, stimulating T cell activation, proliferation and cytokine production. OX40L is expressed on antigen presenting cells including B cells, dendritic cells, mast cells and endothelium.

UniProt: P23510